This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Tait D Shanafelt: Innovator in Hematologic Cancer Treatment
Introduction
Tait D Shanafelt is a prominent inventor based in Rochester, MN (US). He has made significant contributions to the field of hematologic cancer treatment. His innovative approaches aim to improve patient outcomes in the management of blood cancers.
Latest Patents
Tait D Shanafelt holds 1 patent for his work titled "Methods of treating hematologic cancers." This patent focuses on the treatment of hematologic cancers, including chronic lymphocytic leukemia (CLL) and acute lymphocytic leukemia (ALL). The methods described involve the administration of EGCG along with a purine nucleoside analog and an alkylating agent.
Career Highlights
Shanafelt is affiliated with the Mayo Foundation for Medical Education and Research, where he continues to advance research in hematologic oncology. His work has garnered attention for its potential to enhance therapeutic strategies for patients suffering from blood cancers.
Collaborations
One of his notable collaborators is Neil E Kay, with whom he has worked on various research initiatives aimed at improving cancer treatment methodologies.
Conclusion
Tait D Shanafelt's contributions to the field of hematologic cancer treatment exemplify the impact of innovative research on patient care. His dedication to advancing medical science continues to inspire future developments in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile